Addiction: from biology to policy. David Nutt FMedSci Imperial College London
|
|
- Eunice Osborne
- 5 years ago
- Views:
Transcription
1 Addiction: from biology to policy David Nutt FMedSci Imperial College London
2 What is addiction? From Latin addictio = enslaved a strong desire to take the drug, difficulties in controlling its use, persisting in its use despite harmful consequences,
3 Addictions To drugs including alcohol and tobacco To gambling - money? Shopping sex internet +/- porn - food??? Work/research/learning/psychiatry??
4 Addictions To drugs including alcohol and tobacco Drugs and alcohol = biggest international trade in world To gambling - illegal drugs 2nd only to oil? Shopping sex internet +/- porn - food? UK costs > 50bill per year
5 Drug related deaths - UK 90,000 80,000 70,000 60,000 50,000 40,000 30,000 20,000 1,400 1,200 1, ,000 0 Tobacco Alcohol Opiates Source: Smoking and drinking among adults, Office for National Statistics Drug Misuse Declared: Findings from the 2010/11 British Crime Survey England and Wales. Home Office Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2009/10: Sweep 6 report. The Centre for Drug Misuse Research 5
6 More than 20% of all male deaths yrs due to alcohol Male deaths from alcohol by age band 2,500 30% Number of deaths 2,000 1,500 1,000 25% 20% 15% 10% % of all deaths by age group 500 5% Age group Wholly attributable conditions Partially attributable acute consequences Partially attributable chronic conditions % of all deaths by age group 0% Figure 1. Number (% of all deaths in each age group) of male deaths attributable to alcohol consumption by age and type of condition (2005) Alcohol the most common reason for death in men under 50
7 Half of all years olds are drunk once a month
8 The rise and rise of liver deaths 80% liver deaths due to alcohol British Liver Trust analysis of Office for National Statistics mortality statistics covering all deaths related to liver dysfunction covering ICD K70 76 and other codes including C22 24 (liver cancer), and B15 B19 (viral hepatitis), January 2009
9 The more you drink the more comorbid diseases you get ause-specific relative risk by alcohol consumption 5.0 Lip, pharynx, and oral cancer Oesophageal cancer Colon cancer Rectal cancer Ischaemic heart disease Relative risk This is the excuse for doing nothing! 0.0 Relative risk Liver cancer Laryngeal cancer Breast cancer Essential hypertension Injuries Men and women Men Women Relative risk Ischaemic stroke Haemorrhagic stroke Cirrhosis Non-cirrhotic chronic liver disease Chronic pancreatitis Alcohol (units/week) Alcohol (units/week) Alcohol (units/week) Alcohol (units/week) Alcohol (units/week) White et al. BMJ 2002;325(7357):191 8
10 Triangulating addiction Social factors Drug factors Addiction Brain mechanisms Personal biological factors
11 Elements of addiction Loss of control Pleasure Reduce suffering Memory Meaning Wanting impulsivity Compulsion Habit Withdrawal
12 Brain circuits of addiction (a) Red = reward prediction and pleasure No-Go Go Blue = cognitive control Green = motivation drive and salience attribution Purple = learning and memory (b) Normal brain Addicted brain Baler and Volkow 2006
13 Elements of addiction Loss of control Pleasure Reduce suffering Memory Meaning Wanting impulsivity Compulsion Habit Use/exposure Withdrawal Perpetuation/addiction
14 What do we know about use? Addictive drugs are usually pleasurable when first taken? Not tobacco, alcohol Pleasurable effects determined by dose speed of brain entry Withdrawal by duration and dose speed of clearance (CYP450 genes)
15 Reducing use reduces harm Use increases mortality: with alcohol consumption exponential rise Lifetime risk of death due to alcohol-related injury 18 Risk of death (%) Men Women Alcohol consumption (g/day) Rehm et al. Addiction 2011;106(Suppl 1):
16 Reducing high-end consumption has major impact on harms Lifetime risk of death due to alcohol-related injury 18 Risk of death (%) Men Women Reductions in high consumers big health benefits Alcohol consumption (g/day) Rehm et al. Addiction 2011;106(Suppl 1):
17 The Times 20 th March 2000 i.v. marks = faster inputs more addiction
18 Time course of heroin effects: short half-life; highs and withdrawal High Effect normal Withdrawal 24 Time (hours) 48
19 Methadone reduces the chaotic effects of heroin and blocks on-top use High Slower and lower high Longer action Effect W/drwl Time (hours) Buprenorphine better blockade and extended action of up to 3 days
20 Speeding up cocaine Leaf Powder [HCl] Crack [freebase]
21 Speed of brain entry predicts stimulant abuse High abuse Low abuse
22 Treatment targets? Loss of control Pleasure Reduce suffering Memory Meaning Wanting impulsivity Compulsion Habit Use/exposure Withdrawal Perpetuation/addiction
23 Possible neurotransmitters Dopamine GABA/gluta mate Loss of control Noradrenaline Dopamine Endorphins Pleasure Reduce suffering Memory impulsivity Meaning Wanting Compulsion Habit Endorphins 5HT? Dopamine Withdrawal Multiple drug related
24 Stopping use? Dopamine GABA/gluta mate Loss of control?noradrenaline? Dopamine Pleasure Reduce suffering Memory impulsivity Meaning Wanting Compulsion Habit Endorphins 5HT? Dopamine Withdrawal Multiple drug related
25 Stopping use Block the drug getting to its binding site Antagonists - naltrexone for heroin (low compliance) (Dopamine reuptake blockers failed for cocaine) Vaccines nicotine, cocaine (under study) Block elements of drugs effects Opioid antagonists for alcohol nalmefene naltrexone? Prevent loss of control Substitution therapy Methadone, buprenorphine for heroin GHB, baclofen for alcohol Varenicline for tobacco
26 Dopamine and addiction What we know In preclinical studies many drugs release dopamine coc >>others (DiChiara) low DRD2 receptor number predicts impulsivity and intake of cocaine but not opioids (Dalley) and similar findings in primate (Nader)
27 dopamine = reward? Increases in brain dopamine are associated with reward effects of psychostimulants in humans Volkow et al 1999
28 But not all drugs release dopamine Heroin 50mg i.v. gives a good high 4000 AUC Change from Baseline (+/- St. Err) [ *[ +[ Sleepy Urge Crave Gouched Withdrawal High Rush Placebo Hydromoprhone Heroin + p<0.05 paired t-test vs. placebo * p<0.05 unpaired t-test heroin vs hydromorphone Daglish MRC, Williams TM, Wilson SJ, Taylor LG, Eap CB, Augsburger M, Giroud C, Brooks DJ, Myles JS, Grasby P, Lingford- Hughes AR, Nutt DJ [2008] Brain dopamine response in human heroin addiction. Brit J Psychiatry 193: PMID:
29 But No difference there is NO in 11 release C-Raclopride of dopamine binding +/- opiate agonist & to controls C_Raclopride BP Right Putamen Right Caudate Right Vent. Striatum Left Putamen Left Caudate Left Vent. Striatum Placebo Hydromorphone Heroin Control Daglish MRC, Williams TM, Wilson SJ, Taylor LG, Eap CB, Augsburger M, Giroud C, Brooks DJ, Myles JS, Grasby P, Lingford- Hughes AR, Nutt DJ [2008] Brain dopamine response in human heroin addiction. Brit J Psychiatry 193: PMID:
30 Dopamine and addiction What we know In humans Only stimulants reliably release dopamine (Volkow etc) Dopamine-rich areas esp n accumbens respond to stimulant drugs to drug cues and reward Dopamine promoting drugs eg agonists and L-DOPA in Parkinson s can lead to addictive-like behaviour Dopamine receptor and uptake blockers have little therapeutic value exception = bupropion (Zyban) in smoking
31 Behavioural pattern of drug use predicts effects of dopamine-acting drugs in stimulant users? Behavioural endophenotype a) Behavioral performance b) Task-related brain activation during drug-word Stroop during drug-word Stroop low compulsive stimulant users highly compulsive stimulant users low compulsive stimulant users highly compulsive stimulant users Amisulpride Placebo Pramipexole Ersche and Robbins
32 Possible neurotransmitters Dopamine GABA/gluta mate Loss of control?noradrenaline? Dopamine Pleasure Reduce suffering Memory Meaning Wanting impulsivity Compulsion Habit Endorphins 5HT? Dopamine Withdrawal Multiple drug related
33 Unlearning addiction? Addiction is a form of learning - Can we unlearn? - Via enhanced glutamate - D-cycloserine D-cycloserine to augment erasure of addiction? Based on anxiety research in rats (Davies) where D- cycloserine can accelerate erasure (overwriting) of fear memories in humans (Ressler) by enhancing glutamate function
34 Our pilot study in Mean AUQ Score alcoholics Watson et al 2011 Mean AUQ Score D- Cycloserine group- craving scores Base line Day 1 Day 2 Day 3 Exp 1 Pre Exp 1 Post Exp 2 Pre Exp 2 Post Exp 3 Pre Exp 3 Post Exp 4 Pre Placebo group- craving scores Day 1 Day 2 Day 3 Exp 4 Post Base line Exp 1 Pre Exp 1 Post Exp 2 Pre Exp 2 Post Exp 3 Pre Exp 3 Post Exp 4 Pre Exp 4 Post
35 Endorphins and opioid receptors Dopamine GABA/gluta mate Loss of control Noradrenaline Dopamine Endorphins Pleasure Reduce suffering Memory impulsivity Meaning Wanting Compulsion Habit Endorphins 5HT? Dopamine Withdrawal Multiple drug related
36 Endogenous opioids system may be a major aspect of addiction Heroin mu opioid receptor Mu Receptor KO mice have reduced heroin alcohol - cocaine intake (Keifer) Increase in brain opioid receptors in humans (and rats) - Cocaine, opiate and alcohol withdrawal Opioid antagonists naltrexone and nalmefene Reduce heroin use Reduce alcohol relapse Reduce alcohol intake Challenge is getting patients to take them depots
37
38 Increase in opiate receptor availability in the brain in early abstinence from alcohol and opiates * Receptor Availability (Vd) Control alcohol dependent opiate dependent n = 28 n = 11 n = 10 Subject Type Bristol studies Williams et al Brit J Psychiatry 2007 ENP 2009 B 11C-diprenorphine * : significantly different to control p<0.05
39 In alcohol dependence opioid receptor PET binding correlates with craving craving score r=0.785 p=0.012 Volume of distribution L Anterior Cingulate R Anterior Cingulate [11C] diprenorphine VD Early withdrawal - Ant cingulate Williams et al 2009 Also in cocaine [Volkow, Zubietta] and opioid dependence [Williams] Total craving score Late withdrawal 3 months?recovery Ant cingulate
40 Nalmefene (mu receptor antagonist) reduces heavy drinking days in alcohol dependence Adjusted change from baseline in monthly HDD (FAS, OC, MMRM) Nalmefene Placebo Adjusted mean and 95% CI * * * * * * Baseline Nalmefene: 19.4 Placebo: 19.6 Month HDD=heavy drinking days; FAS=full analysis set; OC=observed cases; MMRM=mixed-effect model repeated measure; CI=confidence interval Mann et al. Biol Psychiatry Epub ahead of print
41 And improves liver enzyme profiles Study 801 (randomised: 403 patients; nalmefene=242, placebo=161) GGT ALAT Placebo Nalmefene GGT, UI * ALAT, UI * Study month Study month *p<0.05 vs placebo; GGT=Gamma-glutamyl transpeptidase;alat=alanine-aminotransferase Adapted from Karhuvaara et al. Alcohol Clin Exp Res 2007;31:
42 How drugs may work in alcohol dependence Acamprosate Nalmefene/Naltrexone? Decrease pleasure? Reduce loss of control Cues/triggers drink lapse relapse Disulfiram (fear of bad effects) Disulfiram (feel sick) Nutt DJ and Lingford-Hughes A (2008) Addiction: the clinical interface. Brit J Pharmacol 154:
43 Possible neurotransmitters Dopamine GABA/gluta mate Loss of control Noradrenaline Dopamine Endorphins Pleasure Reduce suffering Memory impulsivity Meaning Wanting Compulsion Habit Endorphins 5HT? Dopamine Withdrawal GABA alcohol Multiple drug related
44 GABA Major inhibitory neurotransmitter in brain Receptors are target for alcohol, benzodiazepines, GHB, other sedatives Molecular site of alcohol action is known in 3 rd transmembrane region Jung and Harris 2006 J Neurochem
45 GABA-A receptor subtypes Molecular complexity being unraveled x x x x x x x x What subtypes involved in addiction? McKernan and Whiting x
46 GABA A subtypes - distribution in rat brain Predicted actions of alcohol Sedation, ataxia Anxiolytic Anxiolytic Learning, pleasure, memory impairing actions of alcohol
47 In hippocampus many 5 receptors are extrasynaptic provide tonic inhibition 1 2 5
48 5 Inverse Agonist selectively attenuates 5 GABA A receptor activity X40 5IA G A B A 100nA 90s 5 GABA A receptor % modulation of GABA EC Log [ 5IA] (M) -55 % Whole-cell patch clamp recording in a mammalian cell line nanomolar affinity for the 5 receptor subtype high inverse agonist activity at the 5 receptor subtype little activity at other GABA A receptor subtypes
49 5IA reverses alcohol s amnestic 14 effect in humans 12 number of words recalled Max score = 20 Normal control ~ 8-10 words 2 0 Placebo + alcohol Nutt et al 2007 Neuropharmacology P< IA +alcohol Blood alcohol = ~ 130 mg%
50 Proof of concept of alcohol antagonist Could other effects be blocked by inverse agonists at other GABA-A receptor subtypes? Ataxia Aggression Liking Could GABA enhancers make a safer alcohol? particularly if had antagonist (antidote) Could 5 receptors play an etiologic role?
51 Imaging human - 5 GABA-A receptors 11 C-Ro a selective tracer Note not in the rat accumbens where is 2 N accumbens Anterior cingulate cortex Hippocampus Lingford-Hughes et al 2002 J Cereb Blood Flow Metab
52 5 receptors in human brain highest density in accumbens 12 * * * Controls Alcoholics 7 VD Hippocampus_r Hippocampus_l Amygdala_r Amygdala_l Ant_TL_med_r Ant_TL_med_l Ant_TL_lat_r Ant_TL_lat_l G_paraH_amb_r G_paraH_amb_l G_sup_temp_r G_sup_temp_l G_tem_midin_r G_tem_midin_l G_occtem_la_r G_occtem_la_l Cerebellum_r Cerebellum_l Brainstem Insula_l Insula_r OL_rest_lat_l OL_rest_lat_r G_cing_ant_l G_cing_ant_r G_cing_post_l G_cing_post_r FL_mid_fr_G_l FL_mid_fr_G_r PosteriorTL_l PosteriorTL_r PL_rest_l PL_rest_r CaudateNucl_l CaudateNucl_r NuclAccumb_l NuclAccumb_r Putamen_l Putamen_r Thalamus_l Thalamus_r Pallidum_l Pallidum_r Corp_Callosum FrontalHorn_r FrontalHorn_l TemporaHorn_r TemporaHorn_l ThirdVentricl FL_precen_G_l FL_precen_G_r FL_strai_G_l FL_strai_G_r FL_OFC_AOG_l FL_OFC_AOG_r FL_inf_fr_G_l FL_inf_fr_G_r FL_sup_fr_G_l FL_sup_fr_G_r PL_postce_G_l PL_postce_G_r PL_sup_pa_G_l PL_sup_pa_G_r OL_ling_G_l OL_ling_G_r OL_cuneus_l OL_cuneus_r FL_OFC_MOG_l FL_OFC_MOG_r FL_OFC_LOG_l FL_OFC_LOG_r FL_OFC_POG_l FL_OFC_POG_r Region Lingford-Hughes et al 2010 Journal of Psychopharmacology
53 11 C-Ro binding in n accumbens reduced in alcoholics 13.5 nuc_accumb_l 13.5 nuc_accumb_r VD 10.5 VD Alcoholics Group Controls 7.5 Alcoholics Group Controls L Nuc Accumbens t = 4.18; p < 0.01 Lingford-Hughes et al 2011 Journal of Psychopharmacology R Nuc Accumbens t = 4.23; p < 0.01
54 Addiction is a complex, variable and multifaceted state Different elements with different behavioural and molecular mechanisms New treatments may require a more fine-grained analysis of these factors and clarity of processes across species Personalised treatment may be the best way forward Loss of control Pleasure Reduce suffering Memory Meaning Wanting impulsivity Compulsion Habit Withdrawal
55
ICCAM platform. Introduction. David Nutt November 2011
ICCAM platform Introduction David Nutt November 2011 The ICCAM Platform New Drugs to Treat Addiction: Can a Knowledge of Brain Mechanisms Help? An MRC addiction cluster Imperial College London: David Nutt
More informationThe future of pharmacological treatment.
The future of pharmacological treatment. Anne Lingford-Hughes Professor of Addiction Biology, Imperial College. Hon Consultant CNWL NHS Foundation Trust. What substances and when? What Nicotine Alcohol
More informationAlcohol: Its effects on the brain and implications for future treatment. Dr Mark Daglish
Alcohol: Its effects on the brain and implications for future treatment Senior Lecturer in Addiction Psychiatry University of Queensland Dr Mark Daglish Director of Addiction Psychiatry Royal Brisbane
More informationMedication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.
Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation
More informationTHE STATE OF MEDICINE IN ADDICTION RECOVERY
OVERVIEW: Review addiction stats and trends Define addiction Explain neurobiology of addiction Review treatments of addiction Addiction Definition: A Primary, chronic, relapsing disease of brain reward,
More informationMood Disorders and Addictions: A shared biology?
Mood Disorders and Addictions: A shared biology? Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Disclosures No relevant disclosures: No paid
More informationUnderstanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO
Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year
More informationLong term pharmacotherapy for Alcohol Dependence: Anti Craving agents
Long term pharmacotherapy for Alcohol Dependence: Anti Craving agents Myth or Reality? Complete Recovery means a medication-free state True or False? Treatment of Alcoholism Assessment Motivation Alcohol
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationRiunione Monotematica AISF 2017 Roma 5 Ottobre Management of Alcohol Use Disorders in Patients with Alcoholic Liver Disease
Riunione Monotematica AISF 2017 Roma 5 Ottobre 2017 Management of Alcohol Use Disorders in Patients with Alcoholic Liver Disease Lorenzo Leggio, M.D., Ph.D., M.Sc. Lorenzo Leggio, M.D., Ph.D., M.Sc. Il
More information6B / Boswell, Grant and Slutske Day 2 August 14, 2008
Pharmacological Treatment of Pathological Gambling Jon E. Grant, JD, MD, MPH Associate Professor University of Minnesota School of Medicine Minneapolis, MN Disclosure Information I have the following financial
More informationTHE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.
THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.
More informationDefining & diagnosing addiction
Defining & diagnosing addiction Jürgen Rehm TUD Dresden, CAMH Toronto et al. No COI for this topic, but in general support from WHO, NIH, pharmaceutical companies (Tx for alcohol dependence) Tuesday 24th
More informationPharmacotherapy for Substance Use Disorders
Pharmacotherapy for Substance Use Disorders Vanessa de la Cruz, MD Chief of Psychiatry Mental Health and Substance Abuse Services Santa Cruz County Health Services Agency 1400 Emeline Avenue Santa Cruz,
More informationMain Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders
Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?
More informationManagement of Tobacco Dependence. Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur
Management of Tobacco Dependence Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur Difficult to identify any other condition that presents such a mix of lethality, prevalence,
More informationMedical Interventions for Addiction in Primary Care Settings. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine
Medical Interventions for Addiction in Primary Care Settings R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine March 23, 2010 NIH Consensus on Drug Treatment Drug Addiction
More informationBRAIN MECHANISMS OF REWARD AND ADDICTION
BRAIN MECHANISMS OF REWARD AND ADDICTION TREVOR.W. ROBBINS Department of Experimental Psychology, University of Cambridge Many drugs of abuse, including stimulants such as amphetamine and cocaine, opiates
More informationEvidence-Based Treatment Approaches for Gambling Disorder
Evidence-Based Treatment Approaches for Gambling Disorder Jon E. Grant, JD, MD, MPH Professor University of Chicago Pritzker School of Medicine Chicago, IL 6/8/2016 Disclosure Information My research is
More information590,000 deaths can be attributed to an addictive substance in some way
Mortality and morbidity attributable to use of addictive substances in the United States. The Association of American Physicians from 1999 60 million tobacco smokers in the U.S. 14 million dependent on
More informationThe Neurobiology of Drug Addiction
National Institute on Drug Abuse (NIDA) The Neurobiology of Drug Addiction Last Updated January 2007 https://www.drugabuse.gov 1 Table of Contents The Neurobiology of Drug Addiction Section I: Introduction
More informationThaddeus Ulzen MD FRCP(C)FAPA FCGP Professor & Chair, Department of Psychiatry and Behavioral Medicine, Associate Dean for Academic Affairs
Thaddeus Ulzen MD FRCP(C)FAPA FCGP Professor & Chair, Department of Psychiatry and Behavioral Medicine, Associate Dean for Academic Affairs CCHS/University of Alabama School of Medicine Assessment History
More informationNeuroscience of Addiction
Neuroscience of Addiction Carlton Erickson, Ph.D. Associate Dean for Research and Graduate Studies Distinguished Professor of Pharmacology Director, Addiction Science Research and Education Center College
More informationAddiction as a Neuropsychiatric Medical Condition
Addiction as a Neuropsychiatric Medical Condition Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse 5 November 2009 Summary
More informationNEUROBIOLOGY ALCOHOLISM
NEUROBIOLOGY ALCOHOLISM THERE HAS BEEN A MAJOR THEORETICAL SHIFT IN MEDICATION DEVELOPMENT IN ALCOHOLISM Driven by animal models of intermittent ethanol administration followed by termination, then access
More informationBASIC VOLUME. Elements of Drug Dependence Treatment
BASIC VOLUME Elements of Drug Dependence Treatment Module 3 Principles of CBT and relapse prevention strategies Introduction to Cognitive Behavioural Therapy Basics of pharmacological treatment Workshop
More informationKnowing How Gamblers Think: Improving Treatment Outcomes
Knowing How Gamblers Think: Improving Treatment Outcomes Jon E. Grant, JD, MD, MPH Professor University of Minnesota School of Medicine Minneapolis, MN Disclosure Information I have the following financial
More information8/5/2013. MOSBIRT Annual Training The Big change in addiction medicine? Before we dive into pharmacotherapy
Medication Assisted Treatment for Substance Abuse in Primary Care Dan Vinson August 1, 2013 1 The Big change in addiction medicine? These diseases are rapidly becoming medical diseases. Done are the days
More informationAlcoholism has been demonstrated to have a genetic component, especially among men.
Causes and Treatment of Substance-Related Disorders (Chapter 10) Familial and Genetic Influences Alcoholism has been demonstrated to have a genetic component, especially among men. Seems to be a common
More informationUnderstanding Addiction
Understanding Addiction How Addiction Hijacks the Brain Addiction involves craving for something intensely, loss of control over its use, and continuing involvement with it despite adverse consequences.
More informationDOES THE D 3 DOPAMINE RECEPTOR (D 3 r)play A ROLE IN ADDICTION? Isabelle Boileau, PhD
DOES THE D 3 DOPAMINE RECEPTOR (D 3 r)play A ROLE IN ADDICTION? Isabelle Boileau, PhD Acknowledgments Human Neurochemical Pathology Lab Stephen J. Kish, PhD Jun Chao Tong, PhD Centre for Movement Disorders
More informationUNDERSTANDING THE DISEASE OF ADDICTION by Suresh Joseph
UNDERSTANDING THE DISEASE OF ADDICTION by Suresh Joseph Summary of Presentation Addiction as a disease Medical harm of substance use Treatment models for substance dependence Local support services for
More informationDisclosure Information I have the following financial relationships to disclose:
Gambling and Other Addictive Disorders Jon E. Grant, JD, MD, MPH Professor University of Chicago Disclosure Information I have the following financial relationships to disclose: My research is supported
More informationMedical Management of Substance Use Disorders: Does research translate to clinical practice
Medical Management of Substance Use Disorders: Does research translate to clinical practice Ashwin A Patkar, MD Professor of Psychiatry & Community & Family Medicine Duke University Medical Center Durham,
More informationMOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre
1 MOLECULAR BIOLOGY OF DRUG ADDICTION Sylvane Desrivières, SGDP Centre Reward 2 Humans, as well as other organisms engage in behaviours that are rewarding The pleasurable feelings provide positive reinforcement
More informationMedications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?
Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives
More informationBiological Addictions Treatment. Psychology 470. Many Types of Approaches
Many Types of Approaches Biological Addictions Treatment Psychology 470 Introduction to Chemical Additions Steven E. Meier, Ph.D. Listen to the audio lecture while viewing these slides Detoxification approaches
More informationNeurobiology of Addiction. Jon E. Grant, JD, MD, MPH Professor University of Chicago
Neurobiology of Addiction Jon E. Grant, JD, MD, MPH Professor University of Chicago Disclosure Information I have the following financial relationships to disclose: My research is supported by NIDA, AFSP,
More informationVarenicline and Other Pharmacotherapies for Tobacco Dependence
Varenicline and Other Pharmacotherapies for Tobacco Dependence J. Taylor Hays, M.D. Associate Director Nicotine Dependence Center Mayo Clinic 2012 MFMER slide-1 Learning Objectives Understand the mechanism
More informationRelevance of craving in eating behaviors
Relevance of craving in eating behaviors Mélina FATSEAS Université Bordeaux CNRS, USR 3413 Pôle Addictologie CH Charles Perrens Craving as a key clinical symptom of addictive disorders Core component of
More informationUnit II Problem 7 Pharmacology: Substance Abuse, Dependence and Addiction
Unit II Problem 7 Pharmacology: Substance Abuse, Dependence and Addiction Drugs are classified as being Used (medically approved) abused (medically NOT approved) - What is the difference between dependence
More informationADHD & Addictions -What We Know
ADHD & Addictions -What We Know Dr. David Teplin, Psy.D., C.Psych. 4th CADDAC Annual Conference, Toronto October 14, 2012 1 Introduction Adult ADHD commonly co-exists with several other disorders, including
More informationNICOTINE PHARMACOLOGY and PRINCIPLES of ADDICTION. 3 rd of 3 Prep for Session 1
NICOTINE PHARMACOLOGY and PRINCIPLES of ADDICTION 3 rd of 3 Prep for Session 1 CHEMISTRY of NICOTINE Pyridine ring N H N CH 3 Pyrrolidine ring Nicotiana tabacum Natural liquid alkaloid Colorless, volatile
More informationKey Concepts. Machinery of the Mind. The Growing Cycle. Six Brain Mind Functions. Machinery of the Mind 6/1/2012
Machinery of the Mind How High-risk Choices Redesign the Brain Key Concepts Brain and Mind are reciprocal Brain/Mind Functions intertwine We are hardwired and we have software Your brain changes all the
More informationThe Neurobiology of Drug Addiction
The Neurobiology of Drug Addiction Glen R. Hanson, Ph.D., D.D.S. Director, Utah Addiction Center Professor of Pharmacology and Toxicology, U of U Senior Advisor, NIDA Drug Abuse and Addiction are Among
More informationnucleus accumbens septi hier-259 Nucleus+Accumbens birnlex_727
Nucleus accumbens From Wikipedia, the free encyclopedia Brain: Nucleus accumbens Nucleus accumbens visible in red. Latin NeuroNames MeSH NeuroLex ID nucleus accumbens septi hier-259 Nucleus+Accumbens birnlex_727
More informationPrepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry
Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry In broad terms, substance use disorders occur when a substance is used in a compulsive manner with a lack of control over
More informationImaging studies have provided new insights on the role of dopamine (DA) in drug abuse and
NEUROLOGICAL REVIEW Dopamine in Drug Abuse and Addiction Results of Imaging Studies and Treatment Implications Nora D. Volkow, MD; Joanna S. Fowler, PhD; Gene-Jack Wang, MD; James M. Swanson, PhD; Frank
More informationThe available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines
The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs
More informationAmerica is a drugged society
Overview of Drug Abuse Basic Considerations. M. Imad Damaj, Ph.D. Associate Professor Dept. of Pharmacology/Toxicology, Virginia Commonwealth University America is a drugged society 90% of all drugs manufactured
More informationHIV and alcohol use: why is risk reduction in alcohol use important in HIV care?
HIV and alcohol use: why is risk reduction in alcohol use important in HIV care? Susanne Astrab Fogger, DNP, PMHNP-BC, CARN-AP, FAANP sfogger@uab.edu Objectives for today s session Define alcohol use disorder
More informationAddiction Overview. Diane A. Rothon MD. Causes Consequences Treatments. Methadone/Buprenorphine 101 April 1, 2017
Addiction Overview Causes Consequences Treatments Methadone/Buprenorphine 101 April 1, 2017 Diane A. Rothon MD Why? would you listen to this presentation Review the definition and neurobiology of addiction
More informationDiscover the Hope: Opiate Treatment and Recovery
Discover the Hope: Opiate Treatment and Recovery The Continued Struggle to Find and Implement Best Practices Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of
More informationAddiction Medicine: What s new for primary care
Addiction Medicine: What s new for primary care Dan Vinson, MD Family and Community Medicine How to talk so our patients listen, and listen so our patients talk. 1 2 Comfortably engaging your patient in
More informationC AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS
C AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS 1.0 Introduction Medications are used in the treatment of drug, alcohol and nicotine dependence to manage
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance
More informationThe Neurobiology of Addiction
The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly
More informationPage 1. Pharmacologic Interventions for. Addictions. Objectives for This Talk. Outline for This Talk
Pharmacologic Interventions for Addictions Eric C. Strain, M.D. Johns Hopkins University School of Medicine, Baltimore, Maryland Maryland Psychiatric Society November 7, 2015 Objectives for This Talk I.
More informationPharmacologic Interventions for. Addictions
Pharmacologic Interventions for Addictions Eric C. Strain, M.D. Johns Hopkins University School of Medicine, Baltimore, Maryland Maryland Psychiatric Society November 7, 2015 Objectives for This Talk I.
More informationPsychotropic Drugs Critical Thinking - KEY
Open Your Class with This Tomorrow Chasing the Scream: The First and Last Days of the War on s Psychotropic s Critical Thinking - KEY Background: The blood-brain barrier is a network of tightly packed
More informationAddictions Pharmacotherapy
Addictions Pharmacotherapy Thomas Kosten MD Associate Vice President for Research JH Waggoner Chair & Professor of Psychiatry, Pharmacology & Neuroscience Baylor College of Medicine Disclosure Thomas Kosten,
More informationAnalgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015
Analgesia for Patients with Substance Abuse Disorders Lisa Jennings CN November 2015 Definitions n Addiction: A pattern of drug use characterised by aberrant drug-taking behaviours & the compulsive use
More information4 th largest seaside town in UK 2 nd most densely populated Most densely populated which is 100% seaside Typical presentation for a town of its
Glyn Halksworth 4 th largest seaside town in UK 2 nd most densely populated Most densely populated which is 100% seaside Typical presentation for a town of its scale. Or is it? Tourism and alcohol Regional
More informationUnderstanding Addiction and Dugs Of Abuse
Understanding Addiction and Dugs Of Abuse Wilkie A. Wilson, Ph.D. DukeLEARN wawilson@duke.edu There is a lot of epidemiological evidence that addiction begins before brain maturity, and lately some biological
More informationOpiate Addiction: Treatment Perspectives
Opiate Addiction: Treatment Perspectives Daniel H. Angres M.D., Director, Positive Sobriety Institute Chief Medical Officer, RiverMend Health Addiction Services Adjunct Associate Professor of Psychiatry,
More informationNoel Schenk MD. Davis Behavioral Health
Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by
More informationNational Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says
National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says Last Updated February 2016 https://www.drugabuse.gov 1 Table of Contents Understanding Drug Abuse and Addiction:
More informationIf you give any person a prescription of something like Valium and have them take it on
As always I am happy to do this presentation, which is my favorite topic in addiction medicine. I am an internist, and I have done healthcare for the homeless in Springfield as well as been the medical
More informationUnderstanding Alcohol And Other Drugs Of Abuse
Understanding Alcohol And Other Drugs Of Abuse Wilkie A. Wilson, Ph.D. DukeLEARN www.dukelearn.com Duke University Medical Center 1 We teach people to respect their hearts... Exercise Eat good food Reduce
More informationNeurobiology of Substance and Gambling Addictions
Neurobiology of Substance and Gambling Addictions Jon E. Grant, JD, MD, MPH Professor University of Chicago Disclosure Information I have the following financial relationships to disclose: My research
More informationDr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging.
David W. Oslin, MD University of Pennsylvania Philadelphia VAMC Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging. Dr. Oslin is a consultant to the Hazelden Betty
More informationUpdate on Medications for Tobacco Cessation
Update on Medications for Tobacco Cessation Marc Fishman MD Johns Hopkins University Dept of Psychiatry Maryland Treatment Centers Baltimore MD MDQuit Best Practices Conference Jan 2013 Nicotine Addiction
More informationBrief Intervention for Smoking Cessation. National Training Programme
Brief Intervention for Smoking Cessation National Training Programme Introduction Monitor tobacco use and prevention policies Protect people from tobacco smoke Offer help to quit tobacco use Warn about
More informationGuideline for GP s in primary care for safe prescribing of acamprosate in Sheffield
Guideline for GP s in primary care for safe prescribing of acamprosate in Sheffield Authors Dr O Lagundoye-Consultant Psychiatrist/Clinical Director MBBS MRCPsych Substance Misuse Service, Sheffield Health
More informationThe Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison
The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison Attitudes about addiction and recovery throughout history Disease?
More informationAddiction 101. Steve Hanson - Associate Commissioner NYS OASAS
Addiction 101 Steve Hanson - Associate Commissioner NYS OASAS After lunch Psychopharmacology Lecture Basic Questions Why do people do drugs? Why can t/ won t some people stop? Realities 1. People like
More informationKey concepts in psychopharmacology
Key concepts in psychopharmacology David Nutt Anne Lingford-Hughes Agonists, antagonists and partial agonists and antagonists at dopamine D 2 receptors Full agonist: dopamine, apomorphine Abstract Drugs
More informationHow Addiction Affects the Brain: The Neuroscience of Compulsive Behavior
How Addiction Affects the Brain: The Neuroscience of Compulsive Behavior Table of Contents INTRODUCTION.... 3 NEUROSCIENCE 101: NEURONS AND NEUROTRANSMITTERS.... 4 BRAIN REGIONS INVOLVED IN ADDICTION:
More informationAlcohol Antagonists 1
Alcohol Antagonists 1 What is an alcohol antagonist? An alcohol antagonist is a drug that specifically blocks the effects of alcohol. If you take an alcohol antagonist and then drink a bunch of alcohol,
More informationTreatment of alcohol addiction with high-dose Baclofen. A randomised and placebo-controlled study (BACLAD) (European Neuropsychopharmacology, 2015)
Treatment of alcohol addiction with high-dose Baclofen. A randomised and placebo-controlled study (BACLAD) (European Neuropsychopharmacology, 2015) Authors: Christian A. Müller, Olga Geisel, Patricia Pelz,
More informationThe Neuroscience of Addiction: A mini-review
The Neuroscience of Addiction: A mini-review Jim Morrill, MD, PhD MGH Charlestown HealthCare Center Massachusetts General Hospital Disclosures Neither I nor my spouse/partner has a relevant financial relationship
More informationNeurobiology of addiction and why it is important
Neurobiology of addiction and why it is important Stephen Jurd University of Sydney 2016 IF Addiction has a neurobiological basis THEN we should be able to: Define addiction AND Identify relevant neurological
More informationCouncil on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain
Council on Chemical Abuse Annual Conference November 2, 2017 The Science of Addiction: Rewiring the Brain David Reyher, MSW, CAADC Behavioral Health Program Director Alvernia University Defining Addiction
More informationCSAM-SCAM Fundamentals. Cocaine Basics. Presentation provided by David C. Marsh MD CCSAM
CSAM-SCAM Fundamentals Cocaine Basics Presentation provided by David C. Marsh MD CCSAM Chronic Illness Relapsing & Remitting in Course Genetic Predisposition Individual Choice a Factor Environmental Influence
More informationADDICTION ELEMENTS OF ADDICTION. Medication Assisted Treatment of Substance Use Disorders Ron Jackson, MSW, LICSW. Substance Use Disorder DSM 5
ADDICTION Addiction is a brain disease shaped by behavioral and social context. Dr. Alan Leshner, Former Director National Institute on Drug Abuse Drug addiction is associated with altered cortical activity
More informationGenetic Contributors to Alcohol Use and Misuse in Young People
Genetic Contributors to Alcohol Use and Misuse in Young People Marianne BM van den Bree Professor of Psychological Medicine Institute of Psychological Medicine and Clinical Neurosciences MRC Centre for
More informationPharmacotherapy of Alcohol Use Disorders
Pharmacotherapy of Alcohol Use Disorders Roger D. Weiss, MD Professor of Psychiatry, Harvard Medical School Chief, Division of Alcohol and Drug Abuse McLean Hospital rweiss@mclean.harvard.edu Consultant
More informationThe Science of Drug Addiction: Implications for Clinical Practice
The Science of Drug Addiction: Implications for Clinical Practice Jack B. Stein, Ph.D. Director Office of Science Policy and Communications National Institute on Drug Abuse National Institutes of Health
More informationDr. Renner receives honoraria from Reed Medical Education
Substance Use Disorders Symposium on Men s Health Massachusetts Medical Society June 17, 2010 John A. Renner, Jr., M.D. John A. Renner Jr., MD DISCLOSURES Johnson & Johnson Stock Holder Dr. Renner receives
More informationAssociate Medical Director of Addiction Medicine, Summa Physicians Inc., Akron, OH Medical Director Esper Treatment Center, Erie, PA Chief Medical
Associate Medical Director of Addiction Medicine, Summa Physicians Inc., Akron, OH Medical Director Esper Treatment Center, Erie, PA Chief Medical Officer, Interval Brotherhood Home, Akron, OH Director
More informationALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH
ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV
More informationDrugs, The Brain, and Behavior
Drugs, The Brain, and Behavior John Nyby Department of Biological Sciences Lehigh University What is a drug? Difficult to define Know it when you see it Neuroactive vs Non-Neuroactive drugs Two major types
More informationAlcohol And Mood Disorders. L.E. Smit, MD, FRCPC. Objectives. February 8, 2007
Alcohol And Mood Disorders L.E. Smit, MD, FRCPC February 8, 2007 1 Objectives To provide an overview of mood and anxiety disorders and alcohol use disorders. Their prevalence co-morbidity and treatment.
More informationOpioids and Opioid Addiction: Practical Management Approaches
Opioids and Opioid Addiction: Practical Management Approaches Yngvild Olsen, MD, MPH Medical Director Institutes for Behavior Resources Inc/REACH Health Services Conflict of Interest No financial or advisory
More informationNeuroscience of Gambling Addiction. Dr Luke Clark 28 th March 2015 Alberta Gambling Research Institute, Banff
Neuroscience of Gambling Addiction Dr Luke Clark 28 th March 2015 Alberta Gambling Research Institute, Banff Overview Endogenous opioid function in pathological gamblers: understanding the mechanism of
More informationBreaking the Chains of Nicotine Dependence - A Breakthrough Approach
Breaking the Chains of Nicotine Dependence - A Breakthrough Approach Dr Rob Young Senior Lecturer & Consultant Physician Auckland Hospital, New Zealand Smoking Cessation in 2001 Smoking contributes to
More informationCHEMISTRY of NICOTINE PHARMACOLOGY NICOTINE ABSORPTION: BUCCAL (ORAL) MUCOSA NICOTINE ABSORPTION. NICOTINE PHARMACOLOGY and PRINCIPLES of ADDICTION
ICOTIE PHARMACOLOGY and PRICIPLES of ADDICTIO ICOTIE ADDICTIO U.S. Surgeon General s Report Cigarettes and other forms of tobacco are addicting. icotine is the drug in tobacco that causes addiction. The
More informationSuffolk PCT Drug & Therapeutics Committee New Medicine Report
Suffolk PCT Drug & Therapeutics Committee New Medicine Report This drug has been reviewed because it is a product that may be prescribed in primary care. Medicine Nalmefene (Selincro, Lundbeck) Document
More informationOpioid Overdose Epidemic A Crises and Opportunity
Opioid Overdose Epidemic A Crises and Opportunity Samuel M. Silverman MD, FAPA, DFASAM Assistant Clinical Professor, UConn Medical School Director, Medical Education Rushford, A Hartford HealthCare Partner
More informationThe Neurobiology of Street Drugs. Joe Gilboy PA-C Hoag Hospital Emergency Department Irvine, CA. Neuroplasticity. Question #1
The Neurobiology of Street Drugs Joe Gilboy PA-C Hoag Hospital Emergency Department Irvine, CA Question #1 Neuroplasticity is the new field of neurobiology that is based upon which of the following : 1.
More information